Zimmer Biomet, Johnson and Johnson Services, Inc., CONMED were Dominating Europe Knee Cartilage Repair Market In 2021

Europe Knee Cartilage Repair Market is expected to grow with the CAGR of 9.7% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-knee-cartilage-repair-market

Europe knee cartilage repair market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Europe knee cartilage repair market are introducing strong range of products and adopting strategic initiatives such as acquisition, agreement, and new product launches into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

• In August 2021, Zimmer Biomet along with Canary Medical had announced that Food and Drug Administration (FDA), De Novo classification grant to world's first and only smart knee implant, Persona IQ knee implant. This approval would enhance the approval in other regions also and helps the company to expand its business.
• In March 2022, Johnson & Johnson Services, Inc. announced the launch of new products to its knee portfolio, ATTUNE cementless fixed bearing knee with AFFIXIUM 3DP Technology and the ATTUNE Medial Stabilized Knee System. These innovations build on the kinematic features which are designed to revolutionize knee patient care. This has helped the company to increase its knee product portfolio.
• In March 2022, CONMED announced he world’s first ACL reconstruction in virtual reality. The product is launched along with PrecisionOS. The company said that the training module will be available soon. This new knee VRthroscopy enables innovative and realistic way to perform the steps of arthroscopic ACL reconstruction. This collaboration has helped the company to launch innovative products in the market.

Zimmer Biomet is the dominating player in Europe knee cartilage repair market. The other key players existing in the market includes Zimmer Biomet, Johnson and Johnson Services Inc., Conmed, Smith + Nephew, Stryker, B.Braun, Arthrex, Inc., Medacta International, WALDEMAR LINK GMBH & CO. KG, Meril Life Sciences Pvt Ltd, JRI ORTHOPAEDICS, Biotissue SA among others.

Zimmer Biomet

Zimmer Biomet has its headquarters in Indiana, United States. The company was launched in 1927. The company is engaged in providing medical products in different categories including knee, hip and shoulder among others. The company have business segments such as Knees, Hips, S.E.T., Spine & Dental & Others in which knee is market focused.

The company is engaged in Knee, Hip, Shoulder, Sports Medicine, CMF, Restorative Therapies, Thoracic Biologics Cement, Diagnostics, Elbow, Foot & Ankle Limb Salvage Patient-Matched, Implants Pharmaceuticals, Surgical Trauma in which knee is market focused.

For instance,

• In August 2021, Zimmer Biomet along with Canary Medical had announced that Food and Drug Administration (FDA), De Novo classification grant to world's first and only smart knee implant, Persona IQ knee implant. This approval would enhance the approval in other regions also and helps the company to expand its business.

The company has wide presence across North America, Europe, Asia-Pacific, South America and Middle East and Africa. The company also has various subsidiary companies such as Accelero Health Partners, LLC (U.S.), Biomet 3i, LLC (U.S.), Zimmer Biomet Robotics (France), and Zimmer GmbH (GmbH), ReLign Corporation (U.S.) among others.

Johnson and Johnson Services Inc.

Johnson & Johnson Services, Inc. has its headquarters in New Jersey, United States. The company was launched in 1886. The company is engaged in the manufacturing and sale of medical products in health care field. The company have business segments such as Consumer Health, Pharmaceutical and Medical Devices in which knee is market focused.

The company is engaged in Consumer Health, MedTech, and Pharmaceutical Products in which MedTech is market focused.

For instance,

• In March 2022, Johnson & Johnson Services, Inc. announced the launch of new products to its knee portfolio, ATTUNE cement less fixed bearing knee with AFFIXIUM 3DP Technology and the ATTUNE Medial Stabilized Knee System. These innovations build on the kinematic features which are designed to revolutionize knee patient care. This has helped the company to increase its knee product portfolio.

The company has wide presence across North America, Europe, Asia-Pacific, South America and Middle East and Africa. The company also has various subsidiary companies such as Neutrogena (U.S.), Ethicon Inc, (U.S.), Synthes (U.S., Actelion (Switzerland), McNEIL PPC Inc. (U.S.) among others.

CONMED.

CONMED has its headquarters in Florida, United States and was founded in 1970. It is a global medical technology company that specializes in the development of medical devices.

The company is engaged in Orthopedics, Bariatric Surgery, Colorectal Surgery, Dermatology, Gastroenterology, General Surgery, Gynecologic Surgery, Pediatric Surgery, Podiatry, Pulmonology, Thoracic Surgery, and Urologic Surgery in which Orthopedics is market focused.

For instance,

• In March 2022, CONMED announced he world’s first ACL reconstruction in virtual reality. The product is launched along with PrecisionOS. The company said that the training module will be available soon. This new knee VRthroscopy enables innovative and realistic way to perform the steps of arthroscopic ACL reconstruction. This collaboration has helped the company to launch innovative products in the market.

The company has wide presence across North America, Europe, Asia-Pacific, South America and Middle East and Africa. The company also has various subsidiary companies such as Aspen Laboratories, Inc. (U.S.), CONMED Andover Medical, Inc. (U.S.), CONMED Austria GmbH (Austria), CONMED Denmark ApS (Denmark), CONMED Deutschland GmbH (Germany) among others.